Lost Ground: Cancer Screening in the COVID-19 Era
A pandemic-related drop in cancer diagnoses could spell long-term trouble for patients and providers.
A pandemic-related drop in cancer diagnoses could spell long-term trouble for patients and providers.
From - Diagnostic Testing & Emerging Technologies
Astronauts will soon conduct DNA sequencing in space. National Aeronautics and Space Administration's (NASA's) Biomolecule Sequencer investigation will…
From - Diagnostic Testing & Emerging Technologies
Luminex (Austin, Texas) announced this week it will acquire molecular microbiology firm Nanosphere (Northbrook, Ill.) in a cash deal valued at…
From - Diagnostic Testing & Emerging Technologies
At-home testing company Cor (San Francisco) has taken to online crowdfunding to commercialize its blood chemistry device. As of April 6, the company had pledges on…
From - Diagnostic Testing & Emerging Technologies
The Targeted Agent and Profiling Utilization Registry (TAPUR) study began recruiting its first patients last month. The trial, the first clinical trial undertaken by …